The Inner Nuclear Layer in Pediatric Multiple Sclerosis
The INL in POMS shows changes similar to what has been reported in adults, with macular microcysts being much rarer. A lack of cross-sectional association between INL thickness and disease severity may represent the early disease stage with neuroinflammation instead of neurodegeneration being in focus.
Authors
- Hannah Hummel-Abmeier (ORCID: https://orcid.org/0009-0004-9335-2415)
- Sabine Naxer (ORCID: https://orcid.org/0000-0002-4657-8620)
- Peter Huppke (ORCID: https://orcid.org/0009-0004-1183-4905)
- Ella Maria Kadas
- Antonia Kowallick
- Kolja Meier
- Michael Schittkowski (ORCID: https://orcid.org/0000-0001-6504-9532)
- Alexander U. Brandt (ORCID: https://orcid.org/0000-0002-9768-014X)
- Friedemann Paul (ORCID: https://orcid.org/0000-0002-6378-0070)
- Hanna Zimmermann (ORCID: https://orcid.org/0000-0002-0276-8051)
- Frederike Cosima Oertel (ORCID: https://orcid.org/0000-0003-4906-5983)
- Jutta Gärtner (ORCID: https://orcid.org/0000-0003-4108-7109)
- Bianca Knaack
Institutions
- University of California, Irvine (US)
- Max Delbrück Center (DE)
- Humboldt-Universität zu Berlin (DE)
- Universitätsmedizin Göttingen (DE)
- University of Göttingen (DE)
- Freie Universität Berlin (DE)
- Friedrich Schiller University Jena (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1212/nxi.0000000000200387
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Sanofi
- Biogen
- Alexion Pharmaceuticals
- Celgene
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Georg-August-Universität Göttingen
- Sanofi Genzyme